BBOT logo

BBOT

BBOT
0.00
USD
+0.00+0.00%

BBOT: Frequently asked questions

As of September 10, 2026, BridgeBio Oncology Therapeutics Inc. has a market capitalization of $446.2 million, making it a small-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.